DRI Healthcare Trust (DHT.UN) Competitors C$13.03 +3.58 (+37.88%) (As of 11/14/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividend DHT.UN vs. ATT, AGRA, MJ, BIO, BBM, BAMM, LOVE, CSI, CALI, and BOSSShould you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Abattis Bioceuticals (ATT), Agraflora Organics International (AGRA), Amplify Alternative Harvest ETF (MJ), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), BooksAMillion (BAMM), Cannara Biotech (LOVE), Chemesis International (CSI), China Auto Logistics (CALI), and Global X Founder-Run Companies ETF (BOSS). These companies are all part of the "drug manufacturers - specialty & generic" industry. DRI Healthcare Trust vs. Abattis Bioceuticals Agraflora Organics International Amplify Alternative Harvest ETF Bio-Rad Laboratories Blueberries Medical BooksAMillion Cannara Biotech Chemesis International China Auto Logistics Global X Founder-Run Companies ETF DRI Healthcare Trust (TSE:DHT.UN) and Abattis Bioceuticals (CNSX:ATT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends, profitability and community ranking. Is DHT.UN or ATT more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Abattis Bioceuticals' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Abattis Bioceuticals' return on equity.Company Net Margins Return on Equity Return on Assets DRI Healthcare Trust5.02% 2.06% 4.22% Abattis Bioceuticals N/A N/A N/A Does the MarketBeat Community prefer DHT.UN or ATT? Abattis Bioceuticals received 70 more outperform votes than DRI Healthcare Trust when rated by MarketBeat users. However, 75.00% of users gave DRI Healthcare Trust an outperform vote while only 64.89% of users gave Abattis Bioceuticals an outperform vote. CompanyUnderperformOutperformDRI Healthcare TrustOutperform Votes1575.00% Underperform Votes525.00% Abattis BioceuticalsOutperform Votes8564.89% Underperform Votes4635.11% Do analysts prefer DHT.UN or ATT? DRI Healthcare Trust currently has a consensus target price of C$18.00, indicating a potential upside of 38.14%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, equities analysts clearly believe DRI Healthcare Trust is more favorable than Abattis Bioceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DRI Healthcare Trust 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Abattis Bioceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher valuation & earnings, DHT.UN or ATT? DRI Healthcare Trust has higher revenue and earnings than Abattis Bioceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDRI Healthcare TrustC$193.66MN/AC$9.73M-C$0.05-260.60Abattis BioceuticalsN/AN/AN/AN/AN/A Do institutionals & insiders hold more shares of DHT.UN or ATT? 48.4% of DRI Healthcare Trust shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media favor DHT.UN or ATT? In the previous week, DRI Healthcare Trust had 2 more articles in the media than Abattis Bioceuticals. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Abattis Bioceuticals. Abattis Bioceuticals' average media sentiment score of 0.00 beat DRI Healthcare Trust's score of -0.50 indicating that Abattis Bioceuticals is being referred to more favorably in the news media. Company Overall Sentiment DRI Healthcare Trust Negative Abattis Bioceuticals Neutral SummaryDRI Healthcare Trust beats Abattis Bioceuticals on 11 of the 13 factors compared between the two stocks. Ad TradingTips7 Cheap and Good StocksIt's the holy grail of the stock market... Stocks that trade for pennies on the dollar yet have the potential to skyrocket for monster gains. Well, we've uncovered SEVEN such stocks.Simply follow this link and claim your copy today at no charge whatsoever. Get DRI Healthcare Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHT.UN vs. The Competition Export to ExcelMetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapN/AC$1.12BC$5.28BC$6.26BDividend Yield3.26%3.13%4.99%5.36%P/E Ratio-260.60108.1794.4926.29Price / SalesN/A3,362.511,261.501,411.43Price / CashN/A10.0939.6285.13Price / Book1.403.136.533.16Net IncomeC$9.73MC$148.11MC$118.67MC$296.32M7 Day Performance-1.06%-1.71%-1.30%0.09%1 Month Performance-7.65%-4.06%2.17%0.49%1 Year PerformanceN/A92.64%35.08%42.42% DRI Healthcare Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHT.UNDRI Healthcare Trust1.4436 of 5 starsC$13.03+37.9%C$18.00+38.1%N/AC$0.00C$193.66M-260.60N/AAnalyst ForecastGap UpHigh Trading VolumeATTAbattis BioceuticalsN/AN/AN/AN/AC$0.00N/A0.00N/AGap UpAGRAAgraflora Organics InternationalN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeMJAmplify Alternative Harvest ETFN/AN/AN/AN/A$0.00N/A0.007Gap UpBIOBio-Rad LaboratoriesN/AN/AN/AN/A$0.00N/A0.008,000High Trading VolumeBBMBlueberries MedicalN/AN/AN/AN/A$0.00N/A0.008High Trading VolumeBAMMBooksAMillionN/AN/AN/AN/A$0.00N/A0.00142High Trading VolumeLOVECannara BiotechN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeCSIChemesis InternationalN/AN/AN/AN/A$0.00N/A0.00147,000Gap DownHigh Trading VolumeCALIChina Auto LogisticsN/AN/AN/AN/A$0.00N/A0.0040Gap DownHigh Trading VolumeBOSSGlobal X Founder-Run Companies ETFN/AN/AN/AN/A$0.00N/A0.00N/AGap DownHigh Trading Volume Related Companies and Tools Related Companies Abattis Bioceuticals Competitors Agraflora Organics International Competitors Amplify Alternative Harvest ETF Competitors Bio-Rad Laboratories Competitors Blueberries Medical Competitors BooksAMillion Competitors Cannara Biotech Competitors Chemesis International Competitors China Auto Logistics Competitors Global X Founder-Run Companies ETF Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:DHT.UN) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DRI Healthcare Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share DRI Healthcare Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
